Pentraxins in the reactions of innate and aquired immunity, matrix organization, and female fertility



Cite item

Full Text

Abstract

A review of literature data and own investigations of the author and //s staff devoted to pentraxin superfamily. The major members of the superfamily are characterized: classic short pentraxins C-reactive protein and serum amyloid P component, long pentraxins PTX3 and PTX4, a group of neuronal pentraxins. We consider the phylogeny of pentraxins, genetic coding, cytokine regulationof synthesis, ligands, biological properties, role in protection against infectious, inflammatory reaction, the organization of the extracellular matrix, fertility.

Full Text

Restricted Access

References

  1. Васильевых Л.А., Назаров П.Г. Влияние интерлей-кина-2 на синтез С-реактивного белка лимфоцитами больных ревматоидным полиартритом // Тез. 1 -го Всесоюз. иммунол. съезда. 1989.
  2. Галкина Е.В., Назаров П.Г., Полевщиков A.B. и др. (Galkina E.V., Nazarov P.G., Polevschikov A.V. et al.) Interactions of C-reactive protein and serum amyloid P component with interleukin-8 and their role in regulation of neutrophil functions // Russ. J. Immunol. 2000. Vol. 5. № 4. P. 363-374.
  3. Галкина E.B., Назаров П.Г., Полевщиков A.B., Берестовая Л.К. Моделирование реакций воспаления в матриксе рыхлой соединительной ткани in vitro. Взаимодействия между С-реактивным белком, сывороточным амилоидом Р и фибронектином и их влияние на адгезию и миграцию нейтрофилов человека // Иммунология. 1999. № 1. С. 41-44.
  4. Лобзин B.C., Назаров П.Г., Чухловина М.Л., Руденко Д.И. Влияние тимуса на синтез С-реактивного белка и ДНК в лимфоцитах больных миастенией: стимулированных митогенами и ИЛ-2 // Иммунология. 1992. № 2. С. 41-43.
  5. Нагорнев В.А., Косицкая Л.С., Рабинович B.C., Назаров П.Г. Структурно-функциональная морфология реакции “острой фазы" печени при экспериментальной гиперхолестеринемии // Бюл. экспер. биол. мед. 1998. Т. 125. № 4. С. 460-464.
  6. Нагорнев В.А., Назаров П.Г., Полевщиков A.B. и др. Атерогенез и реакция «острой фазы» печени // Арх. патол. 1998. Т. 60. № 6. С. 62-68.
  7. Назаров П.Г. (Nazarov P.G.) Complement and reactants of acute phase of inflammation in the processes of functional activity of non-specific resistance and immunoregulation // Russ. J. Immunol. 1999. Vol. 4. № 3. P. 247-250.
  8. Назаров П.Г. (Nazarov P.G.) Neonatally induced CRP deficiency leads to impairment of T-dependent immune response // Abstr. 7th Int. Congr. Immunol. Berlin (West), 1989. Stuttgart-New York: Fisher, 1989. P. 194.
  9. Назаров П.Г. Врожденный иммунитет и защита от инфекций // Russ. J. Immunol. 2005. Vol. 9. № 2. P. 51-55.
  10. Назаров П.Г. Реактанты острой фазы воспаления. СПб.: Наука. 2001.423 с.
  11. Назаров П.Г. Экспериментальный дефицит С-реактивного белка у мышей, индуцированный неонатальной супрессией антителами, и связанные с ним изменения в иммунной системе // Иммунодефицита и аллергия. М., 1986. С. 62-63.
  12. Назаров П.Г., Васильевых Л.А., Руденко Д.И., Лобзин B.C. (Nazarov P.G., Vasiljewykh L.A., Rudenko D.I., Lobzin V.S.) C-reactive protein (CRP) and DNA synthesis in lymphocytes of patients with myasthenia gravis stimulated with mitogens and IL-2. Effects of thymectomy // 1st Int. Congr. ISNIM, Florence, 1990. P. 448.
  13. Назаров П.Г., Васильевых Л.A., Софронов Б.H. и др. (Nazarov P.G., Vasiljewykh L.A., Sofronov B.N. et al.) Effects of IL-2 on C-reactive protein synthesis in lymphocytes of patients with juvenile rheumatoid arthritis//Allergologic. 1989. Sondemum. P. 159-160.
  14. Назаров П.Г., Крылова И.Б., Евдокимова H.Р. и др. С-реактивный белок: фактор воспаления, связывающий и инактивирующий ацетилхолин // Цитокины и воспаление. 2006. Т. 5. № 4. С. 32-35.
  15. Назаров П.Г., Петров И.В., Косицкая Л.С. и др. (Nazarov P.G., Petrov I.V., Kositskaya L.S. et al.) Antibodies to plasma lipoproteins induced by C-reactive protein //Abstr. 62nd EAS Congr. Jerusalem. 1993. P. 90.
  16. Назаров П.Г., Полевщиков A.B. Роль рецепторов интерлейкина-2 в реализации митогениого действия С-реактивного белка на лимфоциты // Вести. РАМН. 1993. №9. С. 13-17.
  17. Назаров П.Г., Полевщиков A.B., Берестовая Л.К. и др. Характеристика антигенных и цитотропных свойств свободных субъединиц С-реактивного белка // Бюл. экспер. биол. мед. 1993. Т. 116. № 12. C. 609-611.
  18. Назаров П.Г., Полевщиков A.B., Галкина Е.В. и др. Пентраксины в процессах неспецифической резистентности и иммунорегуляции // Мед. иммунол. 1999. Т. 1. № 1-2. С. 59-72.
  19. Назаров П.Г., Пронина А.П., Трулев A.C. (Nazarov P.G., Pronina A.P., Trulioff A.S.) C-reactive protein: Fc-gamma receptor-mediated effects on human peripheral blood basophils in vitro // С-Reactive Protein: New Research. Ed. S. Nagasawa. Nova Science Publishers2009. P. 147-169.
  20. Назаров П.Г., Софронов Б.H. Синтез С-реактивного белка лимфоидными клетками // Медиаторы иммунного ответа в эксперименте и клинике. М. 1983. С. 112-113.
  21. Назаров П.Г., Софронов Б.Н. С-реактивный белок в системе иммунорегуляцин // Иммунология. 1986. №4. С. 12-18.
  22. Назаров П.Г., Крылова И.Б., Евдокимова Н.Р. и др. (Nazarov P.G., Krylova I.В., Evdokimova N.R. et al.) C-reactive protein: a pentraxin with anti-acetylcholine activity // Life Sei. 2007. Vol. 80. № 24-25. P. 2337-2341.
  23. Назаров П.Г., Берестовая Л.K., Полевщиков A.B. Значение взаимодействия С-реактивного белка и липопротеидов плазмы для пролиферации лимфоцитов // Иммунология. 1994. №4. С. 15-17.
  24. Назаров П.Г., Берестовая Л.К. Ингибирующее действие С-реактивного белка (СРБ) на гемолитическую активность стрептолизина О. Сравнение конформационных вариантов СРБ // Бюл. экспер. биол. мед. 1995. Т. 119. № 5. С. 506-509.
  25. Назаров П.Г., Берестовая Л.К. Нейтрализующая активность С-реактивного белка в отношении порооб-разующих цитотоксинов бактериального происхождения //Докл. РАН. 1995. Т. 343. № 1. С. 123-126.
  26. Назаров П.Г., Виташенкова Н.В., Киселева Е.П. и др. Влияние C-реактивного белка и его субъединиц на цитотоксический эффект фактора некроза опухолей α в отношении фибробластов линии L929 // Цитология. 1996. Т. 38. № 7. С. 742-750.
  27. Назаров П.Г., Петров П.В., Коспцкая Л.С. и др. Индукция иммунного ответа на липопротсины плазмы С-реактивным белком // Бюл. экспер. биол. мел. 1998. Т. 126. №7. С. 76-79.
  28. Назаров П.Г. Взаимодействие С-реактивного белка с альфа-цепью рецептора ннтерлейкина-2 // Бюл. экспер. биол. мед. 1998. Т. 125. № 6. С. 657-660.
  29. Назаров П.Г. Иммунологические нарушения, связанные с дефицитом С-реактивного белка в организме // Иммунология. 1996. № 3. С. 33-37.
  30. Нежинская Г.И., Лосев H.A., Назаров П.Г., Сапронов Н.С. Влияние ацетилхолина и С-реактивного белка на регуляцию анафилактического шока у морских свинок // Экспер. клин, фармакол. 2005. Т. 68. № 4. С. 49-52.
  31. Нежинская Г.И., Назаров П. Г., Евдокимова H. Р. и др. Холинергическая регуляция анафилактического шока: влияние С-реактивного белка // Цитокины и воспаление. 2004. Т. 3. № 1. С. 44-48.
  32. Полевщиков A.B., Киселева Е.П., Берестовая Л.К., Назаров П.Г. Физиологические закономерности регуляции кислородного метаболизма лейкоцитов крови человека С-реактивным белком // Физиол. человека. 1995. Т. 21. № 2. С. 122-128.
  33. Полевщиков A.B., Назаров П.Г. Влияние С-реактивного белка и нейтрофилов на митоген-индуцированную пролиферацию лимфоцитов человека // Иммунология. 1992. № 6. С. 37-39.
  34. Полевщиков A.B., Назаров П.Г. Тафтсиноподобные пептиды из молекулы С-реактивного белка как модуляторы пролиферации лимфоцитов // Вопр. мед. химии. 1994. Т. 40. № 1. С. 4-7.
  35. Полевщиков A.B., Назаров П.Г., Берестовая Л.К. С-реактивный белок модулирует адгезивную и биоцидную активность нейтрофилов // ЖМЭИ. 1994. № 1. С. 69-72.
  36. Полевщиков A.B., Назаров П.Г., Козлов С.В. и др. Регуляция функций нейтрофилов крови С-реактивным белком и сывороточным амилоидом Р // Физиол. журн. им. И.М. Сеченова. 1996. Т. 82. № 8-9. С. 67-72.
  37. Полевщиков A.B., Назаров П.Г. С-реактивный белок и сывороточный амилоид Р: роль в иммунорегуляции // Иммунология. 1998. № 4. С. 4-11.
  38. Пронина А.П., Назаров П.Г. Активация базофилов крови человека лигандами Fcγ-рецепторов: холинергический тюнинг // Цитокины и воспаление. 2008. Т. 7. № 4. С. 40-46.
  39. Пронина А.П., Назаров П.Г. Тучные клетки: роль в воспалении и иммунных процессах // Вестн. Уральск. мед. акад. науки. 2006. № 3(14). С. 193-195.
  40. Протасова С.Ф., Щеканова С.М., Назаров П.Г., Барклай-де-Толли М.Н. Влияние интерлейкина-2 на продукцию интерферона лимфоцитами человека и значение этого теста при аутоиммунных заболеваниях // Вестн. РАМН. 1996. № I. С. 54-58.
  41. Abderrahim-Ferkoune A., Bezy О., ChielIini C. et al. Characterization of the long pentraxin PTX3 as a TNF α-induced secreted protein of adipose cells // J. Lipid Res. 2003. Vol. 44. P. 994-1000.
  42. Agncllo D., Carvelli L., Muzio V. et al. Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasonc and rolipram // J. Neuroimmunol. 2000. Vol. 109. P. 105-111.
  43. Agrawal A., Cha-Molstad H., Samois D., Kushner I. Transactivation of Creactive protein by 1L-6 requires synergistic interaction of CCAAT/enhancer binding protein ß (С/EBP β) and Rel p50 // J. Immunol. 2001. Vol. 166. P. 2378-2384.
  44. Agrawal A., Cha-Molstad H., Samois D., Kushner I. Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3 // Immunology. 2003. Vol. 108. P. 539-547.
  45. Agrawal A., Samois D., Kushner I. Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPbeta to the promoter // Mol. Immunol. 2003. Vol. 40. P. 373-380.
  46. Agrawal A., Shrive A.K., Greenhough T.J., Volanakis J.E. Topology and structure of the Clq-binding site on C-reactive protein // J. Immunol. 2001. Vol. 166. P. 3998-4004.
  47. Alles V.V., Bottazzi B., Peri G. et al. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes // Blood. 1994. Vol. 84. P. 3483-3493.
  48. Altmeyer A., Klampfer L., Goodman A.R., Vilcek J. Promoter structure and transcriptional activation of the murine TSG-14 gene encoding a tumor necrosis factor/interleukin-1-inducible pentraxin protein // J. Biol. Chem. 1995. Vol. 270. P. 25584-25590.
  49. Andersen O., Vilsgaard Ravn K. Serum amyloid P component binds to influenzaAvirus haemagglutinin and inhibits the virus infection in vitro // Scand. J. Immunol. 1997. Vol. 46. P. 331-337.
  50. Aquilina J.A., Robinson C.V. Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry // Biochem. J. 2003. Vol. 375. P. 323-328.
  51. Armstrong P.B., Swarnakar S., Srimal S. et al. A cytolytic function for a sialic acid-binding lectin that is a member of the pentraxin family of proteins // J. Biol. Chem. 1996. Vol. 271. P. 14717-14721.
  52. Bang R., Mamell L., Mold C. et al. Analysis of binding sites in human C-reactive protein for FcgRl, FcgRIIa and Clq by site-directed mutagenesis //. Biol. Chem. 2005. Vol. 280. P. 25095-25102.
  53. Basile A., Sica A., d’Aniello E. et al. Characterization of the promoter for the human long pentraxin PTX3. Role of NF-кВ in tumor necrosis factor-а and inter-leukin-lβ regulation //. Biol. Chem. 1997. Vol. 272. P. 8172-8178.
  54. Bhakdi S., Torzewski M., Paprotka K. et al. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence // Circulation. 2004. Vol. 109. P. 1870-1876.
  55. Bharadwaj D., Mold C., Markham E., Du Clos T.W. Serum amyloid P component binds to Fey receptors and opsonizes particles for phagocytosis // J. Immunol. 2001. Vol. 166. P. 6735-6741.
  56. Bharadwaj D., Stein M.P., Volzer M. et al. The major receptor for C-reactive protein on leukocytes is Fey receptor II // J. Exp. Med. 1999. Vol. 190. P. 585-590.
  57. Bharadwaj D., Stein M.P., Volzer M. et al. The major receptor for C-reactive protein on leukocytes is Fcg receptor II // J. Exp. Med. 1999. Vol. 190. P. 585-590.
  58. Bickerstaff M.C., Botto M., Hutchinson W.L. et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity // Nat. Med. 1999. Vol. 5. P. 694-697.
  59. Bjarnadottir T.K., Fredriksson R., Hoglund P.J. et al. B. The human and mouse repertoire of the adhesion family of G-protein-coupled receptors // Genomics. 2004. Vol. 84. P. 23-33.
  60. Bodman-Smith K.B., Gregory R.E., Harrison P.T., Raynes J.G. FcgammaRlIa expression with FcgRI results in C-reactive proteinand IgGmediated phagocytosis // J. Leukocyte Biol. 2004. Vol. 75. P. 1029- 1035.
  61. Bodman-Smith K.B., Mbuchi M., Culley F.J. et al. Creactive protein-mediated phagocytosis of Leishmania donovani promastigotes does not alter parasite survival or macrophage responses // Parasite Immunol. 2002. Vol. 24. P. 447-454.
  62. Bottazzi B., Vouret-Craviari V., Bastone A. et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component // J. Biol. Chem. 1997. Vol. 272. P. 32817-32823.
  63. Botto M., Hawkins P.N., Bickerstaff M.C. et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene // Nat. Med. 1997. Vol. 3. P. 855-859.
  64. Breviario F., d’Aniello E.M., Golay J. et al. 1992. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component // J. Biol. Chem. 2003. Vol. 267. P. 22190-22197.
  65. Butler P.J., Tennent G.A., Pepys M.B. Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin // J. Exp. Med. 1990. Vol. 172. P. 13-18.
  66. Cha-Molstad H., Agrawal A., Zhang D., Samols D., Kushner I. The Rel family member P50 mediates cytokineinduced C-reactive protein expression by a novel mechanism / J. Immunol. 2000. Vol. 165. P. 4592-4597.
  67. Chi M., Tridandapani S., Zhong W. et al. Creactive protein induces signaling through FcgRIla on HL-60 granulocytes //. Immunol. 2002. Vol. 168. P. 1413-1418.
  68. De Haas C.J., Van der Tol M.E., Van Kessel K.P. et al. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39. of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood // J. Immunol. 1998. Vol. 161. P. 3607-3615.
  69. Devaraj S., Kumaresan P.R., Jialal I. Effect of C-reactive protein on chemokine expression in human aortic endothelial cells // J. Mol. Cell. Cardiol. 2004. Vol. 36. P. 405-410.
  70. Diniz S.N., Nomizo R., Cisalpino P.S. et al. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages // J. Leukoc. Biol. 2004. Vol. 75. P. 649-656.
  71. Dodds D.C., Omeis I.A., Cushman S.J. et al. Neuronal pentraxin receptor, a novel putative integral membrane pentraxin that interacts with neuronal pentraxin 1 and 2 and taipoxinassociated calcium-binding protein 49 // J. Biol. Chem. 1997. Vol. 272. P. 21488-21494.
  72. Doni A., Peri G., Chieppa M. et al. Production of the soluble pattern recognition receptorPTX3 by myeloid, but not plasmacytoid, dendritic cells // Eur. J. Immunol. 2003. Vol. 33. P. 2886-2893.
  73. Doni A., Mantovani G., Porta C. et al. Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells // J. Biol. Chem. 2008. Vol. 283. P. 29983-29992.
  74. Doni A., Michela M., Bottazzi B. et al. Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma // J. Leukoc. Biol. 2006. Vol. 79. P. 797-802. ~
  75. Du Clos T.W., Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity // Immunol. Res. 2004. Vol. 30. P. 261-278.
  76. Du Clos T.W., Zlock L.T., Rubin R.L. Analysis of the binding of Creactive protein to histones and chromatin // J. Immunol. 1988. Vol. 141. P. 4266-4270.
  77. Du Clos T.W., Zlock L.T., Hicks P.S., Mold C. Decreased autoantibody levels and enhanced survival of. NZB 4 NZW. FI mice treated with C-reactive protein // Clin. Immunol. Immunopathol. 1994.Vol. 70. P. 22-27.
  78. Emsley J., White H.E., O'Hara B.P., Oliva G. et al. Structure of pentameric human serum amyloid P component // Nature. 1994. Vol. 367. P. 338-345.
  79. Familian A., Zwart B., Huisman H.G. et al. Chromatin-independent binding of serum amyloid P component to apoptotic cells // J. Immunol. 2001. Vol. 167. P. 647-654.
  80. Gaboriaud C., Juanhuix J., Gruez A. et al. The crystal structure of the globular head of complement protein Clq provides a basis for its versatile recognition properties // J. Biol. Chem. 2003. Vol. 278. p. 46974-46982.
  81. Garlanda C., Hirsch E., Bozza S. et al. Non-redundant role of the long pentraxin РТХЗ in antifungal innate immune response // Nature. 2002. Vol. 420. P. 182-186.
  82. Gaziano R., Bozza S., Bellocchio S. et al. Combination therapy with pentraxin 3 and antifungals in experimental aspergillosis //Antimicrob. Agents Chemother. 2004. Vol. 48. P. 4414-4421.
  83. Gershov D., Kim S., Brot N., Elkon K.B. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity // J. Exp. Med. 2000. Vol. 192. P. 1353-1364.
  84. Gewurz H., Zhang X.H., Lint T.F. Structure and function of the pentraxins // Curr. Opin. Immunol. 1995. Vol. 7. P. 54-64.
  85. Gilges D., Vinit M.A., Callebaut I. et al. Polydom: a secreted protein with pentraxin, complement control protein, epidermal growth factor and von Willebrand factor A domains // Biochem. J. 2000. Vol. 352. Pt. 1. P. 49-59.
  86. Goodman A.R., Cardozo T., Abagyan R. et al. Long pentraxins: an emerging group of proteins with diverse functions // Cytokine Growth Factor Rev. 1996. Vol. 7. P. 191-202.
  87. Goodman A.R., Levy D.E., Reis L.F., Vilcek J. Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages // J. Leukoc. Biol. 2000. Vol. 67. P. 387-395.
  88. Hind C.R., Collins P.M., Baltz M.L., Pepys M.B. Human serum amyloid P component, a circulating lectin with specificity for the cyclic 4,6-pyruvate acetal of galactose. Interactions with various bacteria // J. Biochem. 1985. Vol. 225. P. 107-111.
  89. Hind C.R., Collins P.M., Renn D. et al. Binding specificity of serum amyloid P component for the pyruvate acetal of galactose // J. Exp. Med. 1984. Vol. 159. P. 1058-1069.
  90. Hirschfield G.M., Herbert J., Kahan M.C., Pepys M.B. Human C-reactive protein does not protect against acute lipopolysaccharide challenge in mice // J. Immunol. 2003. Vol. 171. P. 6046-6051.
  91. Hsu Y.C., Perin M.S. Human neuronal pentraxin II. NPTX2. P. conservation, genomic structure, and chromosomal localization // Genomics. 1995. Vol. 28. P. 220-22T
  92. Hundt M., Zielinska-Skowronek M., Schmidt R.E. Lack of specific receptors for C-reactive protein on white blood cells // Eur. J. Immunol. 2001. Vol. 31. P. 3475-3483.
  93. Hurlimann J., Thorbecke G.J., Hochwald G.M. The liver as the site of Creactive protein formation // J. Exp. Med. 1966. Vol. 123. P. 365-378.
  94. Hutchinson W.L., Hohenester E., Pepys M.B. Human serum amyloid P component is a single uncomplexed pentamer in whole serum // Mol. Med. 2000. Vol. 6. P. 482-493.
  95. Inforzato A., Peri G., Doni A. et al. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with Cl q and complement activation // Biochemistry. 2006. Vol. 45. P. 11540-11551.
  96. Inforzato A., Rivieccio V., Morreale A.P. el al. Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization // J. Biol. Chem. 2008. Vol. 283. P. 10147- 10I61.
  97. Introna M., Alles V.V., Castellano M. et al. Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites // Blood. 1996. Vol. 87. P. 1862-1872.
  98. Jaillon S., Peri G., Delneste Y. et al. The humoral pattern recognition receptor PTX3 is stored in neutropiil granules and localizes in extracellular traps // J. Exp. Med. 2007. Vol. 204. P. 793-804.
  99. Jewell W.S., Mamell L.L., Rokeach L.A., T. Du Clos. W. C-reactive protein. CRP. binding to the Srn-D protein of snRNPS. Identification of a short polypeptide binding region // Mol. Immunol. 1993. Vol. 30. P. 701-708.
  100. Jiang H., Robey F.A., Gewurz H. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human ClqAchain //. Exp. Med. 1992. Vol. 175. P. 1373-1379.
  101. Kim S.J., Gershov D., Ma X. et al. Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses//Ann. N.Y. Acad. Sei. 2003. Vol. 987. P. 68-78.
  102. Kirkpatrick L.L., Matzuk M.M., Dodds D.C., Perin M.S. Biochemical interactions of the neuronal pentraxins. Neuronal pentraxin. NP. receptor binds to taipoxin and taipoxin-associated calcium-binding protein 49 via NP1 and NP2// I. Biol. Chem. 2000. Vol. 275. P. 17786-17792.
  103. Klouche M., Peri G., Knabbe C. et al. Modified atherogenic lipoproteins induce expression of pentrax-in-3 by human vascular smooth muscle cells // Atherosclerosis. 2004. Vol. 175. P. 221-228.
  104. KloucheM., Peri G., Knabbe C. et al. Modified atherogenic lipoproteins induce expression of pentrax-in-3 by human vascular smooth muscle cells // Atherosclerosis. 2004. Vol. 175. P. 221-228.
  105. Kretzschmar D., Hasan G., Sharma S. et al. The swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila // J. Neurosci. 1997. Vol. 17. P. 7425-7432.
  106. Lee G.W., Goodman A.R., Lee Т.Н., Vilcek J. Relationship of TSG-14 protein to the pentraxin family of major acute phase proteins // J. Immunol. 1994. Vol. 153. P. 3700-3707.
  107. Lee G.W., Lee Т.Н., Vilcek J. TSG-14, a tumor necrosis factorand IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins// J. Immunol. 1993. Vol. 150. P. 1804-1812.
  108. Li S.-Р., Liu Т.-Y., Goldman N.D. cis-Acting elements responsible for interleukin-6 inducible C-reactive protein expression // J. Biol. Chem. 1990. Vol. 265. P. 4136-4142.
  109. Li S.P., Goldman N.D. Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements // Biochemistry. 1996. Vol. 35. P. 9060-9068.
  110. Li Y.P., Mold C., Du Clos T.W. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes//J. Immunol. 1994. Vol. 152. P. 2995-3005.
  111. Loveless R.W., Floyd-O'Sullivan G., Raynes J.G. et al. Human serum amyloid P is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphatcd saccharides galactose. N-acetylgalactosamine and glucuronic acid // EMBO J. 1992. Vol. 11. P. 813-819.
  112. Lysenko E., Richards J.C., Cox A.D. et al. The position of phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae affects binding and sensitivity to C-reactive protein-mediated killing // Mol. Microbiol. 2000. Vol. 35. P. 234-245.
  113. Mackievvicz A., Speroff T., Ganapathi M.K., Kushner I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines // J. Immunol. 1991. Vol. 146. P. 3032-3037.
  114. Manolov D.E., Rocker C., Hombach V. et al. Ultrasensitive confocal fluorescence microscopy of C-reactive protein interacting with FcgRIIa // Arterioscler. Thromb. Vase. Biol. 2004. Vol. 24. P. 2372-2377.
  115. Mantovani A., Sozzani S., Locati M. et al. Macrophage polarization. P. tumor-associated macrophages as a paradigm for polarized М2 mononuclear phagocytes // Trends Immunol. 2002. Vol. 23. P. 549-555.
  116. Mantovani A., Garlanda C., Doni A., Bottazzi B. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3 // J. Clin. Immunol. 2008. Vol. 28. P. 1-13.
  117. Milner C.M., Day A.J. TSG-6. P. a multifunctional protein associated with inflammation // J. Cell Sci. 2003. Vol. 116. P. 1863-1873.
  118. Mold C., Baca R., Du Clos T.W. Serum amyloid P component and Creactive protein opsonize apoptotic cells for phagocytosis through Fcγ receptors // J. Autoimmunol. 2002. Vol. 19. P. 147-154.
  119. Mold C., Gresham H.D., Du Clos T.W. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fcγ Rs // J. Immunol. 2001. Vol. 166. P. 1200-1205.
  120. Mold C., Rodriguez W., Rodic-Polic B., Du Clos T.W. C-reactive protein mediates protection from lipopolysaccharide through interactions with Fcγ R // J. Immunol. 2002. Vol. 169. P. 7019-7025.
  121. Mold C., Gewurz H., Du Clos T.W. Regulation of complement activation by C-reactive protein // Immunopharmacology. 1999. Vol. 42. P. 23-30.
  122. Mold C., Gresham H.D., Du Clos T.W. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine FcgRs // J. Immunol. 2001. Vol. 166. P. 1200-1205.
  123. Mold C., Nakayama S., Holzer T.J. et al. C-reactive protein is protective against Streptococcus pneumoniae infection in mice //J. Exp. Med. 1981. Vol. 154. P. 1703-1708.
  124. Mold C., Rodic-Polic B., Du Clos T.W. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fcg receptors // J. Immunol. 2002. Vol. 168. P. 6375-6381.
  125. Mold C., Rodriguez W., Rodic-Polic B., Du Clos T.W. C-reactive protein mediates protection from lipopolysaccharide through interactions with FcgR // J. Immunol. 2002. Vol. 169. P. 7019-7025.
  126. Muller B., Peri G., Doni A. et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients // Crit. Care Med. 2001. Vol. 29. P. 1404-1407.
  127. Narkates A.J., Volanakis J.E. C-reactive protein binding specificities: artificial and natural phospholipid bilayers // Ann. N.Y. Acad. Sei. 1982. Vol. 389. P. 172-181.
  128. Nauta A.J., Bottazzi B., Mantovani A. et ai. Biochemical and functional characterization of the interaction between pentraxin 3 and Clq // Eur. J. Immunol. 2003. Vol. 33. P. 465^473.
  129. Nauta A.J., Daha M.R., van Kooten C., Roos A. Recognition and clearance of apoptotic cells. P. a role for complement and pentraxins //Trends Immunol. 2003. Vol. 24. P. 148-154.
  130. Nauta A.J., de Haij S., Bottazzi B. et al. Human renal epithelial cells produce the long pentraxin PTX3 // Kidney Int. 2005. Vol. 67. P. 543-553.
  131. Ng P.M., Z Jin., Tan S.S. et al. C-reactive protein: a predominant LPS-binding acute phase protein responsive to Pseudomonas infection // J. Endotoxin Res. 2004. Vol. 10. P. 163-174.
  132. Nijmeijer R., Lagrand W.K., Lubbers Y. et al. C-re-active protein activates complement in infarcted human myocardium //Am. J. Pathol. Vol. 163. 2003. P. 269-275.
  133. Noursadeghi M., Bickerstaff M.C., Gallimore J.R. et al. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen // Proc. Natl. Acad. Sei. USA. 2000. Vol. 97. P. 14584-14589.
  134. Omeis I.А., Hsu Y.C., Perin M.S. Mouse and human neuronal pentraxin 1. NPTX1 : conservation, genomic structure, and chromosomal localization 4 Genomics. 1996. Vol. 36. P. 543-545.
  135. Pepys M.B., Butler P.J. Serum amyloid P component is the major calciumdependent specific DNA binding protein of the serum // Biochem. Biophys. Res. Commun. 1987. Vol. 148. P. 308-313.
  136. Pepys M.B., Herbert J., Hutchinson W.L. et al. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis // Nature. 2002. Vol. 417. P. 254-259.
  137. Pepys М.В., Hirschfield G.М. C-reactive protein: a critical update // J. Clin. Invest. 2003. Vol. 111. P. 1805-1812.
  138. Pepys M.B., Rademacher T.W., Amatayakul-Chantler S. et al. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure // Proc. Natl. Acad. Sci. USA. 1994. Vol. 91. P. 5602-5606.
  139. Peri G., Introna M., Corradi D. et al. PTX3, a prototypic long pentraxin, is an early indicator of acute myocardial infarction in man // Circulation 2000. Vol. 102. P. 636-641.
  140. Perrier P., Martinez F.O., Locati M. et al. Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the В cell-activating chemokine. CXC chemokine ligand 13 // J. Immunol. 2004. Vol. 172. P. 7031-7042
  141. Polentarutti N., Bottazzi B., Di Santo E. et al. Inducible expression of the long pentraxin PTX3 in the central nervous system // J. Neuroimmunol. 2000. Vol. 106. P. 87-94.
  142. Polentarutti N., Picardi G., Basile A. et al. Interferonγ inhibits expression of the long pentraxin PTX3 in human monocytes // Eur. J. Immunol. 1998. Vol. 28. P. 496-501.
  143. Ramji D.P., Vitelli A., Tronche F., Cortese R., Ciliberto G. 1993. The two C/EBP isoforms. IL-6DBP/ NF-IL6 and C/EBP δ/NF-IL6 β, are induced by IL6 to promote acute phase gene transcription via different mechanisms // Nucleic Acids Res. Vol. 21. P. 289-294.
  144. Ravizza T., Moneta D., Bottazzi B. et al. Dynamic induction of the long pentraxin PTX3 in the CNS after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration // Neuroscience. 2001. Vol. 105. P. 43-53.
  145. Reid M.S., Blobel C.P. Apexin, an acrosomal pentaxin // J. Biol. Chem. 1994. Vol. 269. P. 32615-32620.
  146. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention // Circulation. 2003. Vol. 107. P. 363-369.
  147. Robey F.A., Liu T.Y. Limulin: a C-reactive protein from Limulus polyphemus // J. Biol. Chem. 1981. Vol. 256. P. 969-975.
  148. Rolph M.S., Zimmer S., Bottazzi B. et al. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques // Arterioscler. Thromb. Vase. Biol. 2002. Vol. 22. P. El 0-El 8.
  149. Rovere P., Peri G., Fazzini F. et al. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells // Blood. 2000. Vol. 96. P. 4300^1306.
  150. Rubio N., Sharp P.M., Rits M. et al. Structure, expression, and evolution of guinea pig serum amyloid P component and C-reactive protein // J. Biochem. 1993. Vol. 113. P. 277-284.
  151. Rusnati M., Camozzi M., Moroni E. et al. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis // Blood. 2004. Vol. 104. P. 92-99.
  152. Russell A.I., Cunninghame Graham D.S., Shepherd C. et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus // Hum. Mol. Genet. Vol. 13.2004. P. 137-147.
  153. Sacland E., van Royen A., Hendriksen K. et al. Human C-reactive protein does not bind to Fcγ Rlla on phagocytic cells // J. Clin. Invest. 2001. Vol. 107. P. 641-643.
  154. Salustri A., Garlanda C., Hirsch E. et al. РТХЗ plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization // Development. 2004. Vol. 131. P. 1577-1586.
  155. Schwartz Y.B., Boykova T., Belyaeva E.S. et al. Molecular characterization of the singed wings locus of Drosophila melanogaster // BMC Genet. 2004. Vol. 5. P. 15.
  156. Seery L.T., Schoenberg D.R., Barbaux S. et al. Identification of a novel member of the pentraxin family in Xenopus laevis // Proc. Biol. Sei. 1993. Vol. 253. P. 263-270.
  157. Shrive A.K., Cheetham G.M., Holden D. et al. Three dimensional structure of human C-reactive protein // Nat. Struct. Biol. 1996. Vol. 3. P. 346-354.
  158. Shrive A.K., Metcalfe A.M., Cartwright J.R., Greenhough T.J. C-reactive protein and SAP-like pentraxin are both present in Limulus polyphemus haemo-lymph: crystal structure of Limulus SAP // J. Mol. Biol. 1999.Vol. 290. P. 997-1008.
  159. Shrive A.K., Cheetham G.M., Holden D. et al. Three dimensional structure of human C-reactive protein // Nat. Struct. Biol. 1996. Vol. 3. P. 346-354.
  160. Srinivasan N., White H. E., Emsley J. et al. Comparative analyses of pentraxins: implications for protomer assembly and ligand binding // Structure. 1994. Vol. 2. P. 1017-1027.
  161. Stein M.P., Edberg J.C., Kimberly R.P. et al. C-reactive protein binding to FcgRIIa on human monocytes and neutrop//ls is allele-specific 7 J. Clin. Invest. 2000. Vol. 105. P. 369-376.
  162. Swanson J.A., Hoppe A.D. The coordination of signaling during Fc receptor-mediated phagocytosis // J. Leuk. Biol. 2004. Vol. 76. P. 1093-1103.
  163. Szalai A.J. The antimicrobial activity of C-reactive protein // Microbes Infect. 2002. Vol. 4. P. 201-205.
  164. Szalai A.J., Alarcon G.S., Calvo-Alen J. et al. Systemic lupus erythematosus in a multiethnic US Cohort. LUMINA. : XXX. Association between C-reactive protein. CRP. gene polymorphisms and vascular events // Rheumatology. Oxford. 2005. Vol. 44. P. 864-868.
  165. Szalai A.J., Briles D.E., Volanakis E. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice // J. Immunol. 1995. Vol. 155. P. 2557-2563.
  166. Szalai A.J., Nataf S., Hu X.Z., Bamum S.R. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein // J. Immunol. 2002. Vol. 168. P. 5792-5797.
  167. Szalai A.J., VanCott J.L., McGhee J.R. et al. Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice // Infect. Immunol. 2000. Vol. 68. P 5652- 5656.
  168. Szalai A.J., Wu J., Lange E.M., McCrory M.A. et al. Single-nucleotide polymorphisms in the C-reactive protein. CRP gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level // J. Mol. Med. 2005. Vol. 83. P. 440-447.
  169. Szalai A.J., Weaver C.T., McCrory M.A. et al. Delayed lupus onset in. NZB 4 NZW. FI mice expressing a human C-reactive protein transgene // Arthritis Rheum. 2003. Vol. 48. P 1602-1611.
  170. Tebo J.M., Mortensen R.F. Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937 // J. Immunol. 1990. Vol. 144. P. 231-238.
  171. Tennent G.A., Lovat L.B., Pepys M.B. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis // Proc. Natl. Acad. Sei. USA. 1995. Vol. 92. P. 4299-4303.
  172. Tilg H., Vannier E., Vachino G., Dinarello C.A. et al. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of Interleukin 1. IL1. receptor antagonist over IL-lb synthesis by human peripheral blood mononuclear cells // J. Exp. Med. 1993. Vol. 178. P. 1629-1636.
  173. Tillett W.S., Francis T.J. Serological reactions in pneumonia with a non protein somatic fraction of pneumococcus // J. Exp. Med. 1930. Vol. 52. P. 561-585.
  174. Toniatti C., Demartis A., Monaci P. et al. Synergistic transactivation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites // EMBO J. 1990. Vol. 9. P. 4467-4475.
  175. Tsui C.C., Copeland N.G., Gilbert D.J. et al. Narp, a novel member of the pentraxin family, promotes neunte outgrowth and is dynamically regulated by neuronal activity // J. Neurosci. 1996. Vol. 16. P. 2463-2478.
  176. Varani S., Elvin J.A., Yan C.N. et al. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility // Mol. Endocrinol. 2002. Vol. 16. P. 1154-1167.
  177. Volanakis J.E., Kaplan M.H. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide // Proc. Soc. Exp. Biol. Med. 1971. Vol. 136. P. 612-614.
  178. Vouret-Craviari V., Matteucci C., Peri G. et al. Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan // Infect. Immunol. 1997.Vol. 65. P. 1345-1350.
  179. Wang Q., Zhu X., Xu Q. et al. Effect of Creactive protein on gene expression in vascular endothelial cells // Am. J. Physiol. Heart Circ. Physiol. 2005.Vol. 288. P. 1539-1545.
  180. Weiser J.N., Pan J. Adaptation of Haemophilus influenzae to acquired and innate immunity based on phase variation of lipopolysaccharide // Mol. Microbiol. 1998. Vol. 30. P. 767-775.
  181. Weiser J.N., Pan N., McGowan K.L. et al. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein // J. Exp. Med. 1998. Vol. 187. P. 631-640.
  182. Williams T.N., Zhang C.X., Game B.A. et al. C-reactive protein stimulates MMP-1 expression in U937 histocytes through FcgRII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization // Arterioscler. Thromb. Vase. Biol. 2004. Vol. 24. P. 61-66.
  183. Wisniewski H.G., Vilcek J. Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14 // Cytokine Growth Factor Rev. 2004.Vol. 15. P. 129-146.
  184. Wolbink G.J., Brouwer M.V., Buysmann S. et al. CRP-mediated activation of complement in vivo // J. Immunol. 1996. Vol. 157. P. 473-479.
  185. Xia D., Samols D. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia // Proc. Natl. Acad. Sei. USA. 1997. Vol. 94. P. 2575-2580.
  186. Xu D.S., Hopf C., Reddy R. et al. Narp and NPlform heterocomplexes that function in developmental and activity-dependent synaptic plasticity // Neuron. 2003. Vol. 39. P. 513-528.
  187. Ying S.C., Gewurz A.T., Jiang H., Gewurz H. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen like region of Clq // J. Immunol. 1993. Vol. 150. P. 169-176.
  188. Yother J., Volanakis J.E., Briles D.E. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice // J. Immunol. 1982. Vol. 128. P. 2374-2376.
  189. Zahedi K. Characterization of the binding of serum amyloid P to laminin // J. Biol. Chem. 1997. Vol. 272. P. 2143-2148.
  190. Zhang D., Jiang S.L., Rzewnicki D., Samols D., Kushner I. The effect of interleukin-I on C-reactive protein expression in НерЗВ cells is exerted at the transcriptional level // Biochem. J. 1995. Vol. 310. Pt. 1. P. 143-148.
  191. Zhang D., Sun M., Samols D., Kushner I. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6 // J. Biol. Chem. 1996. Vol. 271 P. 9503-9509.
  192. Zhong S., Zen Q., Tebo J. et al. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling // J. Immunol. Vol. 161. 1998. P. 2533-2540.

Copyright (c) 2010 Nazarov P.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies